IL18BP
Basic information
Region (hg38): 11:71998613-72007315
Links
Phenotypes
GenCC
Source:
- hepatitis, fulminant viral, susceptibility to (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hepatitis, fulminant viral, suspectibility to | AR | Allergy/Immunology/Infectious | The condition has been described as involving susceptibilty to fulminant viral hepatitis as well as other autoimmune manifestations, and awareness may allow prompt and aggressive management of infectious and related sequelae | Allergy/Immunology/Infectious | 31213488 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL18BP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 24 | ||||
missense | 66 | 74 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 9 | 1 | 10 | |||
non coding | 46 | 11 | 64 | |||
Total | 0 | 0 | 136 | 23 | 11 |
Variants in IL18BP
This is a list of pathogenic ClinVar variants found in the IL18BP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-71999989-CCAT-C | Uncertain significance (Apr 30, 2022) | |||
11-71999991-A-G | Uncertain significance (Sep 08, 2023) | |||
11-72000002-CTG-C | Uncertain significance (Dec 25, 2022) | |||
11-72000010-C-G | Uncertain significance (Dec 22, 2023) | |||
11-72000013-G-GT | Uncertain significance (Mar 08, 2023) | |||
11-72000018-C-T | Uncertain significance (Jan 12, 2024) | |||
11-72000021-T-A | Uncertain significance (Oct 23, 2022) | |||
11-72000025-G-A | Uncertain significance (Nov 02, 2022) | |||
11-72000028-A-G | Uncertain significance (Oct 09, 2023) | |||
11-72000030-G-A | Uncertain significance (Mar 03, 2023) | |||
11-72000030-GC-AT | Uncertain significance (Jul 05, 2022) | |||
11-72000332-G-A | Uncertain significance (Mar 01, 2022) | |||
11-72000332-G-C | Uncertain significance (May 21, 2022) | |||
11-72000333-T-C | Uncertain significance (Oct 16, 2022) | |||
11-72000347-T-A | Uncertain significance (Oct 05, 2023) | |||
11-72000348-C-G | Uncertain significance (Oct 30, 2022) | |||
11-72000352-C-T | Uncertain significance (Jun 08, 2022) | |||
11-72000353-C-T | not specified | Uncertain significance (Sep 25, 2023) | ||
11-72000358-C-A | not specified | Uncertain significance (Nov 03, 2023) | ||
11-72000363-T-C | not specified | Uncertain significance (Jun 17, 2024) | ||
11-72000373-G-A | Likely benign (Nov 18, 2023) | |||
11-72000376-C-A | Likely benign (Jan 15, 2024) | |||
11-72000376-C-T | Benign (Dec 11, 2023) | |||
11-72000384-C-T | Uncertain significance (Jan 29, 2024) | |||
11-72000386-C-A | Uncertain significance (Mar 26, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IL18BP | protein_coding | protein_coding | ENST00000404792 | 5 | 7175 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.48e-8 | 0.0635 | 124749 | 0 | 56 | 124805 | 0.000224 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.554 | 126 | 110 | 1.15 | 0.00000626 | 1229 |
Missense in Polyphen | 31 | 22.579 | 1.373 | 293 | ||
Synonymous | -0.749 | 54 | 47.4 | 1.14 | 0.00000272 | 414 |
Loss of Function | -0.541 | 11 | 9.23 | 1.19 | 4.79e-7 | 95 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000151 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00100 | 0.00100 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000142 | 0.000141 |
Middle Eastern | 0.00100 | 0.00100 |
South Asian | 0.000599 | 0.000556 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Isoform A binds to IL-18 and inhibits its activity. Functions as an inhibitor of the early TH1 cytokine response. {ECO:0000269|PubMed:10023777, ECO:0000269|PubMed:10655506}.;
- Pathway
- Signaling by Interleukins;Cytokine Signaling in Immune system;Interleukin-18 signaling;Purine metabolism;Immune System;Interleukin-37 signaling;Interleukin-1 family signaling
(Consensus)
Recessive Scores
- pRec
- 0.0732
Intolerance Scores
- loftool
- 0.645
- rvis_EVS
- 0.26
- rvis_percentile_EVS
- 70.26
Haploinsufficiency Scores
- pHI
- 0.0408
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.500
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Il18bp
- Phenotype
- hematopoietic system phenotype; reproductive system phenotype; liver/biliary system phenotype; immune system phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- response to lipopolysaccharide;interleukin-18-mediated signaling pathway;T-helper 1 type immune response;cellular response to hydrogen peroxide;cellular response to cytokine stimulus;cellular response to tumor necrosis factor;extracellular negative regulation of signal transduction
- Cellular component
- extracellular region;extracellular space;extracellular exosome
- Molecular function
- interleukin-18 binding;receptor antagonist activity